First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal cancer — before they become cancerous. Study aims to ...
A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...
This article is part of "Build IT: Connectivity," a series about tech powering better business. Viome is aiming to transform disease detection, starting with the gut. The Washington-based biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback